Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Alzheimer’s and Parkinson’s diseases predict different COVID-19 outcomes, a UK Biobank study

View ORCID ProfileYizhou Yu, View ORCID ProfileMarco Travaglio, View ORCID ProfileRebeka Popovic, View ORCID ProfileNuno Santos Leal, View ORCID ProfileL. Miguel Martins
doi: https://doi.org/10.1101/2020.11.05.20226605
Yizhou Yu
MRC Toxicology Unit, University of Cambridge
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yizhou Yu
Marco Travaglio
MRC Toxicology Unit, University of Cambridge
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marco Travaglio
Rebeka Popovic
MRC Toxicology Unit, University of Cambridge
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rebeka Popovic
Nuno Santos Leal
MRC Toxicology Unit, University of Cambridge
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nuno Santos Leal
L. Miguel Martins
MRC Toxicology Unit, University of Cambridge
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for L. Miguel Martins
  • For correspondence: martins.lmiguel@gmail.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

In December 2019, a coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began infecting humans causing a novel disease, coronavirus disease 19 (COVID-19). This was first described in the Wuhan province of the People’s Republic of China. SARS-CoV-2 spread throughout the world causing a global pandemic. To date, thousands of cases of COVID-19 were reported in the United Kingdom, and over 45,000 patients have died. Some progress has been achieved in managing this disease, but the biological determinants of health, besides age, that affect COVID-19 infectivity and mortality are under scrutiny. Recent studies show that several medical conditions, including diabetes and hypertension, increase the risk of COVID-19 infection and death. The increased vulnerability of the elderly and those with comorbidities, together with the prevalence of neurodegenerative diseases with advanced age, led us to investigate the links between neurodegeneration and COVID-19. We analysed the primary health records of 13,338 UK individuals tested for COVID-19 between March and July 2020. We show that a pre-existing diagnosis of Alzheimer’s disease predicts the highest risk of COVID-19 infection and mortality among the elderly. In contrast, Parkinson’s disease patients were found to be at increased risk of infection but not mortality from COVID-19. We conclude that there are disease-specific differences in COVID-19 susceptibility among patients affected by neurodegenerative disorders.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study is funded by the UK Medical Research Council, intramural project MC_UU_00025/3 (RG94521)

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

UK Biobank ethical approval was granted from the North West Multi-Centre Research Ethics Committee. The current analysis was approved under the UK Biobank application 60124

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Code available in GitHub

https://m1gus.github.io/AD_PD_COVID19/

  • Abbreviations

    AD
    Alzheimer’s disease
    COPD
    Chronic obstructive pulmonary disease
    COVID-19
    Coronavirus disease-19
    PD
    Parkinson’s disease
    SARS-CoV-2
    Severe acute respiratory syndrome coronavirus 2
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted November 07, 2020.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Alzheimer’s and Parkinson’s diseases predict different COVID-19 outcomes, a UK Biobank study
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Alzheimer’s and Parkinson’s diseases predict different COVID-19 outcomes, a UK Biobank study
    Yizhou Yu, Marco Travaglio, Rebeka Popovic, Nuno Santos Leal, L. Miguel Martins
    medRxiv 2020.11.05.20226605; doi: https://doi.org/10.1101/2020.11.05.20226605
    Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    Citation Tools
    Alzheimer’s and Parkinson’s diseases predict different COVID-19 outcomes, a UK Biobank study
    Yizhou Yu, Marco Travaglio, Rebeka Popovic, Nuno Santos Leal, L. Miguel Martins
    medRxiv 2020.11.05.20226605; doi: https://doi.org/10.1101/2020.11.05.20226605

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Public and Global Health
    Subject Areas
    All Articles
    • Addiction Medicine (62)
    • Allergy and Immunology (142)
    • Anesthesia (46)
    • Cardiovascular Medicine (415)
    • Dentistry and Oral Medicine (70)
    • Dermatology (48)
    • Emergency Medicine (144)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (171)
    • Epidemiology (4861)
    • Forensic Medicine (3)
    • Gastroenterology (183)
    • Genetic and Genomic Medicine (676)
    • Geriatric Medicine (70)
    • Health Economics (192)
    • Health Informatics (630)
    • Health Policy (321)
    • Health Systems and Quality Improvement (206)
    • Hematology (85)
    • HIV/AIDS (156)
    • Infectious Diseases (except HIV/AIDS) (5343)
    • Intensive Care and Critical Care Medicine (331)
    • Medical Education (93)
    • Medical Ethics (24)
    • Nephrology (75)
    • Neurology (686)
    • Nursing (42)
    • Nutrition (115)
    • Obstetrics and Gynecology (126)
    • Occupational and Environmental Health (208)
    • Oncology (440)
    • Ophthalmology (140)
    • Orthopedics (36)
    • Otolaryngology (90)
    • Pain Medicine (35)
    • Palliative Medicine (16)
    • Pathology (129)
    • Pediatrics (194)
    • Pharmacology and Therapeutics (131)
    • Primary Care Research (84)
    • Psychiatry and Clinical Psychology (781)
    • Public and Global Health (1817)
    • Radiology and Imaging (325)
    • Rehabilitation Medicine and Physical Therapy (138)
    • Respiratory Medicine (255)
    • Rheumatology (86)
    • Sexual and Reproductive Health (69)
    • Sports Medicine (62)
    • Surgery (100)
    • Toxicology (23)
    • Transplantation (29)
    • Urology (37)